Patient Advocacy Group asks FDA to Enhance its Enforcement of Unapproved Drugs Initiative.

Business WireMarch 12, 2010

Linked as:

Extract


Patient Advocacy Group asks FDA to Enhance its Enforcement of Unapproved Drugs Initiative.

Agency encouraged to eliminate unapproved drugs that put patients at unnecessary risk

WASHINGTON -- The National Minority Quality Forum (The Forum) is launching a new public...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company